A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine in 546 patients with HBeAg-negative/anti-HBe-positive chronic hepatitis B.

Marcellin P., Lau G., Bonino F., Farci P., Hadziyannis S., Jin R., ...Daha Fazla

54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, BOSTON, MASSACHUSETTS, 24 - 28 Ekim 2003, cilt.38 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 38
  • Basıldığı Şehir: BOSTON
  • Basıldığı Ülke: MASSACHUSETTS
  • Bursa Uludağ Üniversitesi Adresli: Evet